Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
itMSCs in non-ischemic heart failure
NCT02467387Phase 2Completed
- Sponsor
- CardioCell LLC
- Start
- Jun 2014
- Primary completion
- May 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ischemia-tolerant allogeneic mesenchymal bone marrow cells, sponsored by CardioCell LLC. Started Jun 2014; status: completed.
02
Drugs
ischemia-tolerant allogeneic mesenchymal bone marrow cells
Beyond the preview
Go deeper on NCT02467387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467387.